India's Serum Institute seeks approval to conduct local trial for Novavax COVID-19 vaccine

In a UK trial, the same vaccine was found to be 89.3% effective, Serum
CEO Adar Poonawalla said.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-serum-institute-seeks-approval-to-conduct-local-trial-for-novavax-covid-19-vaccine/articleshow/80557135.cms

Comments

Popular posts from this blog

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online